Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Eribulin exhibits a lower extent of distribution across CNS and PNS barriers compared to Cremophor EL/ethanol solubilized paclitaxel: implications for neurotoxicity development
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy.ORCID iD: 0000-0002-3701-3847
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Medicinal Chemistry, Pharmaceutical physical chemistry.ORCID iD: 0000-0001-6534-6115
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences. Uppsala University, Science for Life Laboratory, SciLifeLab. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy.ORCID iD: 0000-0002-9181-1321
Show others and affiliations
(English)Manuscript (preprint) (Other academic)
Keywords [en]
eribulin, paclitaxel, chemotherapy-induced peripheral neurotoxicity, drug distribution, blood-nerve barrier, blood-dorsal root ganglion barrier, blood-brain barrier
National Category
Pharmaceutical Sciences
Research subject
Pharmaceutical Science
Identifiers
URN: urn:nbn:se:uu:diva-598383OAI: oai:DiVA.org:uu-598383DiVA, id: diva2:2101109
Available from: 2026-09-14 Created: 2026-09-14 Last updated: 2026-09-20
In thesis
1. Pharmacokinetic Mechanisms in the Development and Prevention of Chemotherapy-Induced Peripheral Neuropathy
Open this publication in new window or tab >>Pharmacokinetic Mechanisms in the Development and Prevention of Chemotherapy-Induced Peripheral Neuropathy
2026 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Chemotherapy-induced peripheral neuropathy (CIPN) is a major dose-limiting adverse effect of anticancer microtubule-targeting agents (MTAs). However, the pharmacologically active unbound exposure of MTAs at CIPN-relevant sites, including peripheral and central nervous system tissues and skeletal muscle, and its relationship to neurotoxicity and biomarkers remain incompletely characterized. The overall aim of this thesis was to investigate MTAs distribution and intra- and extracellular exposure at CIPN-relevant sites using preclinical models and integrating these findings with pharmacokinetic-pharmacodynamic (PKPD) modelling and biomarker evaluation to improve understanding and monitoring of CIPN in patients.

Particular emphasis was placed on paclitaxel-induced peripheral neuropathy (PIPN), with focus on drug formulation, translational pharmacokinetics, and serum neurofilament light chain (sNfL) as a biomarker of axonal injury. Albumin-bound and micellar paclitaxel formulations showed greater unbound distribution across endothelial barriers at CIPN-relevant sites, expressed as the unbound tissue-to-plasma concentration ratio (Kp,uu,tissue), than paclitaxel formulated with Cremophor EL. Results provide a plausible mechanistic explanation for the higher incidence of CIPN with non-Cremophor EL formulations. Based on PIPN site pharmacokinetic data, a semi-mechanistic PKPD model was developed linking sNfL kinetics to intracellular paclitaxel-tubulin binding in dorsal root ganglia, peripheral nerves, and brain. The framework was translated to humans, where sNfL dynamics were related to the Total Neuropathy Score-clinical version in breast cancer patients. sNfL showed moderate predictive performance for CIPN, highlighting the multifactorial nature of PIPN.

The thesis was subsequently extended to cabazitaxel, docetaxel, vinorelbine, and eribulin to investigate whether differences in CIPN prevalence could be related to MTA distribution at CIPN-relevant sites. Despite differences in the time required to reach steady-state, governed by tubulin abundance and transporter-mediated distribution across endothelial and parenchymal barriers, all MTAs showed a similar distribution pattern, with greater distribution into PNS than CNS tissues. Thus, dissimilarities in clinical unbound plasma exposure, rather than in tissue distribution patterns, may be important determinants of intracellular exposure and neurotoxicity.

Together, the translational framework developed in this thesis links drug exposure, intracellular target engagement, and sNfL dynamics from preclinical to clinical settings. It provides a rationale for PK-informed CIPN assessment and for the development of novel MTAs with reduced neurotoxicity.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2026. p. 72
Series
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy, ISSN 1651-6192 ; 410
Keywords
chemotherapy-induced peripheral neuropathy, blood-dorsal root ganglion barrier, blood-nerve barrier, blood-brain barrier, taxanes, Vinca alkaloids, drug distribution
National Category
Pharmaceutical Sciences
Research subject
Pharmaceutical Science
Identifiers
urn:nbn:se:uu:diva-599159 (URN)978-91-513-2960-4 (ISBN)
Public defence
2026-11-06, Room IV, Biskopsgatan 3, Uppsala, 09:15 (English)
Opponent
Supervisors
Available from: 2026-10-14 Created: 2026-09-20 Last updated: 2026-10-14

Open Access in DiVA

No full text in DiVA

Authority records

Girdenytė, MildaGinosyan, AghavniJadhari, RojitaHammarlund-Udenaes, MargaretaLoryan, Irena

Search in DiVA

By author/editor
Girdenytė, MildaGinosyan, AghavniJadhari, RojitaHammarlund-Udenaes, MargaretaLoryan, Irena
By organisation
Department of PharmacyPharmaceutical physical chemistryDepartment of Pharmaceutical BiosciencesScience for Life Laboratory, SciLifeLab
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 8 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf